2016
DOI: 10.1186/s12886-016-0199-z
|View full text |Cite
|
Sign up to set email alerts
|

Management of intraocular pressure elevation during hemodialysis of neovascular glaucoma: a case report

Abstract: BackgroundIt is generally accepted that dialysis may lower plasma osmolality at a faster rate than changes in ocular osmolality. This osmotic difference causes water to migrate from the plasma into the aqueous humor, increasing intraocular pressure. Certain authors have described IOP increase in patients with narrow angles.Case presentationHere we report a neovascular glaucoma patient who experienced a substantial increase in IOP associated with severe eye pain and blurred vision during sessions of dialysis. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0
4

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 20 publications
(29 reference statements)
0
13
0
4
Order By: Relevance
“…Hemodialysis (HD) is one of the main treatment methods in patients with CRF; its main objective is to correct the excessive accumulation and abnormal distribution of body fluid. However, sometime during or after HD, patients will occasionally develop a sharp increase in intraocular pressure (IOP), followed by transient blurred vision, eye pain, headache, and other symptoms [ 1 , 2 ]. HD can also cause macular edema, ischemic optic neuropathy, retinal hemorrhage, retinal detachment, and other changes [ 3 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Hemodialysis (HD) is one of the main treatment methods in patients with CRF; its main objective is to correct the excessive accumulation and abnormal distribution of body fluid. However, sometime during or after HD, patients will occasionally develop a sharp increase in intraocular pressure (IOP), followed by transient blurred vision, eye pain, headache, and other symptoms [ 1 , 2 ]. HD can also cause macular edema, ischemic optic neuropathy, retinal hemorrhage, retinal detachment, and other changes [ 3 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…For those individuals susceptible to experiencing IOP elevation during HD, chronic elevation in IOP might result in optic nerve damage. Some approaches have been reported to hinder a symptomatic rise in IOP during dialysis, including intravenous mannitol [ 35 ], hypertonic sodium dialysis or use of hyperosmotic agents [ 12 ], slower urea removal [ 36 ], modified dialysis parameters with colloid infusion [ 30 ], and intravenous glucose administration [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mannitol infusion has been tried during dialysis, but this exposes the patient to adverse side effects such as—chest pain, headaches, edema, and rashes . The most recent therapy involved an infusion of 20% hyperosmolar glucose solution at 100 mL/h during dialysis which helped maintain the IOP in the normal range …”
Section: Discussionmentioning
confidence: 99%
“…18 The most recent therapy involved an infusion of 20% hyperosmolar glucose solution at 100 mL/h during dialysis which helped maintain the IOP in the normal range. 19,20 Minguela et al presented a case report showing that a change total conductivity with colloid solution can relieve symptoms and prevent increase in IOP. 21 We present the only reported case that used a higher sodium concentration of dialysis to raise tonicity thereby mitigating IOP fluctuations and risk for ocular dialysis disequilibrium.…”
Section: Changing the Tonicitymentioning
confidence: 99%